Keywords: بازدارنده فعال کننده پلاسمینوژن; VTE; venous thromboembolism; HSCT; hematopoietic stem cell transplant; LMWH; low molecular weight heparin; IMIDs; immunomodulatory drugs; AML; acute myeloid leukemia; IQR; interquartile range; TAT; thrombin antithrombin; FVII; factor VII; FVIII; factor VI
مقالات ISI بازدارنده فعال کننده پلاسمینوژن (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: بازدارنده فعال کننده پلاسمینوژن; Adipocyte; Breast cancer; Tumor-stroma interaction; CAF; cancer-associated fibroblast; WAT; white adipose tissue; CLS; crown-like structure; CAA; cancer-associated adipocyte; ECM; extracellular matrix; IL; interleukin; ER; estrogen receptor; TNBC; triple-
Keywords: بازدارنده فعال کننده پلاسمینوژن; Urinary cell mRNA profiling; Polymerase chain reaction; Rejection; Tolerance; Kidney transplantation; mRNA; messenger RNA; RT-QPCR; real-time quantitative PCR; ACR; acute cellular rejection; ROC; receiver-operating-characteristic; PI-9; proteinase inhibit
Keywords: بازدارنده فعال کننده پلاسمینوژن; A2Ms; α-2- macroglobulins; AFLEI; elastase inhibitor from Aspergillus flavus; AFUEI; elastase inhibitor from Aspergillus fumigatus; AP; α-2-antiplasmin; AT; antithrombin; bFGF; basic fibroblast growth factor; BSuPI; Bacillus subtilis protease inhibitor;
Keywords: بازدارنده فعال کننده پلاسمینوژن; endogenous lysis; plasminogen activator inhibitor; streptokinase; synergy; tissue plasminogen activator; urokinase-type plasminogen activator; AMI; acute myocardial infarction; ICH; intracranial hemorrhage; PCI; percutaneous coronary intervention; pro-uPA
Keywords: بازدارنده فعال کننده پلاسمینوژن; ACTH; adrenocorticotropic hormone; aFGF; acidic fibroblast growth factor; Akt; activation of protein kinase B; ANG; angiogenin; ASCs; adipose tissue-derived mesenchymal stem cells; B7-H1; B7 homolog 1; BDNF; brain-derived neurotrophic factor; bFGF; basic
Keywords: بازدارنده فعال کننده پلاسمینوژن; ATP; adenosine triphosphate; BCRP; breast cancer resistance protein; CKD; chronic kidney disease; COL1A1; collagen type 1A1; ECM; extracellular matrix; ESRD; end-stage renal disease; FN1; fibronectin 1; GAPDH; glyceraldehyde 3-phosphate dehydrogenase; 7-
Keywords: بازدارنده فعال کننده پلاسمینوژن; Single-walled carbon nanotubes; Carbon nanotubes; Nanomaterials; Nanotoxicology; Pulmonary toxicology; Inflammation; Oxidative stress; Inhalation; Pharyngeal aspiration; Intratracheal instillation; ACE; angiotensin-converting enzyme; AD-SWCNTs; acetone/so
Keywords: بازدارنده فعال کننده پلاسمینوژن; 2K-1C; two-kidney one-clip; ACE-Is; angiotensin converting enzyme inhibitors; AL; aliskiren; Ang II; angiotensin II; ANP; atrial natriuretic peptide; APTT; activated partial thromboplastin time; ARBs; AT1 receptor antagonists; ASA; aspirin; Fg; fibrinogen
Keywords: بازدارنده فعال کننده پلاسمینوژن; DDE; p,pâ²-dichlorodiphenyldichloroethylene; HCB; hexachlorobenzene; GIP; gastric inhibitory polypeptide; GLP-1; glucagon-like peptide-1; PAI-1; plasminogen activator inhibitor; PCBs; polychlorinated biphenyls; POPs; persistent organochlorine pollutant;
Keywords: بازدارنده فعال کننده پلاسمینوژن; ABI; ankle-brachial index; ADMA; asymmetric dimethylarginine; CI; confidence interval; CV; coefficient of variation; EDTA; ethylene diamine tetra-acetic acid; eGFR; estimated glomerular filtration rate; HbA1c; glycated hemoglobin; HDL; high-density lipo
Keywords: بازدارنده فعال کننده پلاسمینوژن; PAI-1; plasminogen activator inhibitor; TNF; tumour necrosis factor; ICU; Intensive Care Unit - SOFA: Sepsis-related Organ Failure Assessment score; PAI-1; Sepsis; Severity; Mortality; Outcome; Prognosis;
Keywords: بازدارنده فعال کننده پلاسمینوژن; APS; Antiphospholipid syndrome; HC; Healthy controls; nonAPS-TC; NonAPS thrombosis controls; aPL; Antiphospholipid antibodies; SLE; Systemic lupus erythematosus; PAI; Plasminogen activator inhibitor; SEM; Scanning electron microscopy; MPs; Microparticles;
Keywords: بازدارنده فعال کننده پلاسمینوژن; Carotid stenosis; Cell adhesion; Cell surface markers; Gene expression; Immunophenotyping; Mononuclear cells; Thrombosis; ATF; atrial fibrillation; BP; blood pressure; BMI; body mass index; CV; cardiovascular; CEA; carotid endarterectomy; CDP; carotid dis
Impact of PAI-1 4G/5G and Câ¯>â¯G polymorphisms in acute ST elevation myocardial infarction and stable angina patients: A single center Egyptian study
Keywords: بازدارنده فعال کننده پلاسمینوژن; Coronary artery disease; Plasminogen activator inhibitor; Genetic polymorphism; 4G/5G, C>G;
SIPS as a model to study age-related changes in proteolysis and aggregate formation
Keywords: بازدارنده فعال کننده پلاسمینوژن; AGEs; advanced glycation endproducts; ALP; autophagy-lysosomal pathway; ATM; ataxia teleangiectasia mutated; BrdU; bromodeoxyuridine; DDR; DNA damage response; DOX; doxorubicin; HDFs; Human diploid fibroblasts; H2O2; hydrogen peroxide; ICAM; intercellular
Intracellular calcium and NF-kB regulate hypoxia-induced leptin, VEGF, IL-6 and adiponectin secretion in human adipocytes
Keywords: بازدارنده فعال کننده پلاسمینوژن; (ROS); Reactive oxygen species; ([Ca++]i); Intracellular calcium; (BAPTA-AM); 1,2-Bis(2aminophenoxy)ethane-N,N,Nâ²,Nâ²-tetraacetic acid tetrakis(acetoxymethyl ester); (Fluo 4-AM); 4-(6Acetoxymethoxy-2,7-difluoro-3-oxo-9-xanthenyl)-4â²-methyl-2,2â²-(et
Syndecan-1 inhibits early stages of liver fibrogenesis by interfering with TGFβ1 action and upregulating MMP14
Keywords: بازدارنده فعال کننده پلاسمینوژن; SDC1; syndecan-1; TGFβ1; transforming growth factor-β1; MAPK; matrix activated protein kinase; ECM; extracellular matrix; ERK; extracellular matrix regulated kinase; GSK; glycogen synthase kinase; αSMA; α smooth muscle actin; THBS1; thrombospondin-1;
Association of plasminogen activator inhibitor-1 and vitamin D receptor expression with the risk of keloid disease in a Chinese population
Keywords: بازدارنده فعال کننده پلاسمینوژن; Chinese population; Keloid disease; Peripheral blood lymphocytes; Plasminogen activator inhibitor; Vitamin D receptor;
Mechanisms of allergy and clinical immunologyDeficiency of plasminogen activator inhibitor 2 in plasma of patients with hereditary angioedema with normal C1 inhibitor levels
Keywords: بازدارنده فعال کننده پلاسمینوژن; Hereditary angioedema; C1 inhibitor; bradykinin; plasminogen activator inhibitor; BCIP/NBT; 5-Bromo-4-chloroindolyl phosphate/nitroblue tetrazolium; C1-INH; C1 inhibitor; HAE; Hereditary angioedema; HAE-N; Hereditary angioedema with normal C1 inhibitor le
Bovine lactoferrin suppresses high-fat diet induced obesity and modulates gut microbiota in C57BL/6J mice
Keywords: بازدارنده فعال کننده پلاسمینوژن; bLF; bovine lactoferrin; Gapdh; glyceraldehyde 3-phosphate dehydrogenase; HF; mice fed with high-fat diet through the study; HF-bLF; mice fed with high-fat diet and meanwhile received oral administration of 100âmg/kg BW of bLF for 12 weeks; IL-1β; inte
Sirtuins in vascular diseases: Emerging roles and therapeutic potential
Keywords: بازدارنده فعال کننده پلاسمینوژن; ACE; angiotensin converting enzyme; AICAR; 5-amino-4-imidazolecarboxamide riboside; AMPK; AMP-activated protein kinase; Ang II; angiotensin II; ApoE; apolipoprotein E; AT1R; angiotensin II type 1 receptor; ATM; ataxia telangiectasia mutated; ATP; adenosin
Cytokines in atherosclerosis: Key players in all stages of disease and promising therapeutic targets
Keywords: بازدارنده فعال کننده پلاسمینوژن; Atherosclerosis; Cytokines; Chemokines; Inflammation; Therapeutic avenues; ABC; ATP-binding cassette; ACAT-1; acyl-CoA acyl transferase-1; ADRP; adipocyte differentiation related protein; Apo; apolipoprotein; BMT; bone marrow transplantation; CANTOS; Cana
Systemic treatment and narrowband ultraviolet B differentially affect cardiovascular risk markers in psoriasis
Keywords: بازدارنده فعال کننده پلاسمینوژن; cardiovascular risk; matrix metalloproteinase-9; myeloperoxidase; psoriasis; soluble E-selectin; soluble intercellular adhesion molecule-1; soluble vascular cell adhesion molecule-1; total plasminogen activator inhibitor-1; tumor necrosis factor-alfa inhi
Compound Astragalus and Salvia miltiorrhiza extract suppresses hepatocellular carcinoma progression by inhibiting fibrosis and PAI-1 mRNA transcription
Keywords: بازدارنده فعال کننده پلاسمینوژن; Compound Astragalus and Salvia miltiorrhiza extract; Diethylnitrosamine; Hepatic fibrosis; Hepatocellular carcinoma; Plasminogen activator inhibitor;
Hypercoagulability Markers Predict Thrombosis in Single Ventricle Neonates Undergoing Cardiac Surgery
Keywords: بازدارنده فعال کننده پلاسمینوژن; 21; ATIII; antithrombin III; CI; confidence interval; CPB; cardiopulmonary bypass; FVIII; factor VIII; ICU; intensive care unit; LOS; length of stay; PAI-1; plasminogen activator inhibitor; PC; protein C; PPP; platelet poor plasma; PS; protein S; RFU; rel
Effect of a Congolese herbal medicine used in sickle cell anemia on the expression of plasminogen activators in human coronary aortic endothelial cells culture
Keywords: بازدارنده فعال کننده پلاسمینوژن; Ceiba pentandra (L.) gaertn; Sickle cell anemia; Endothelial cells; Fibrinolysis; Plasminogen activators; Plasminogen activator inhibitor
Polymorphisms of PAI-1 and platelet GP Ia may associate with impairment of renal function and thrombocytopenia in Puumala hantavirus infection
Keywords: بازدارنده فعال کننده پلاسمینوژن; PUUV; Puumala virus; HFRS; hemorrhagic fever with renal syndrome; VWF; von Willebrand factor; PAI; plasminogen activator inhibitor; GP; glycoprotein; NE; nephropathia epidemica; HLA; human leukocyte antigen; HPA; human platelet alloantigen; CBC; complete
Ambient temperature affects thrombotic potential at rest and following exercise
Keywords: بازدارنده فعال کننده پلاسمینوژن; TAT; thrombin-antithrombin III complex; tPA; tissue plasminogen activator; PAI-1; plasminogen activator inhibitor-1; RPE; rating of perceived exertion; tissue plasminogen activator; plasminogen activator inhibitor; thrombin-antithrombin; thrombosis; envir
Increased heparanase level and procoagulant activity in orthopedic surgery patients receiving prophylactic dose of enoxaparin
Keywords: بازدارنده فعال کننده پلاسمینوژن; DVT; deep vein thrombosis; HS; heparan sulfate; TF; tissue factor; TFPI; tissue factor pathway inhibitor; PE; pulmonary emboli; TAT; thrombin-antithrombin; PAI; plasminogen activator inhibitor; LMWH; low molecular weight heparin; TPA; tissue plasminogen a
Protective role of the vitamin D receptor
Keywords: بازدارنده فعال کننده پلاسمینوژن; VDR; vitamin D receptor; RAS; renin-angiotensin system; VDRA; vitamin D receptor agonists; VDRE; vitamin D response elements; RXR; retinoid X receptors; SRC; steroid receptor activator complex; DRIP; vitamin D receptor interacting protein complex; NCoR; n
Postprandial changes in the phospholipid composition of circulating microparticles are not associated with coagulation activation
Keywords: بازدارنده فعال کننده پلاسمینوژن; TAT; thrombin-antithrombin; F1Â +Â 2; prothrombin fragment F1Â +Â 2; PAI; plasminogen activator inhibitor; MP; microparticles; BMI; body mass index; NEFA; non-esterified fatty acids; HDL-C; high-density lipoprotein cholesterol; LDL-C; low-density lipoprot
Regulation of matrix metalloproteinases activity studied in human endometrium as a paradigm of cyclic tissue breakdown and regeneration
Keywords: بازدارنده فعال کننده پلاسمینوژن; ADAM; a disintegrin and metalloproteinase; ECM; extracellular matrix; EGF; epidermal growth factor; GPI; glycosylphosphatidylinositol; HSPG; heparan sulfate proteoglycan; IGF; insulin-like growth factor; IL; interleukin; LRP; low density lipoprotein recep
Influence of Gestational Age on Fibrinolysis from Birth to Postnatal Day 10
Keywords: بازدارنده فعال کننده پلاسمینوژن; ELISA; Enzyme-linked immunosorbent assay; GMH-IVH; Germinal matrix hemorrhage-intraventricular hemorrhage; PAI; Plasminogen activator inhibitor; PVHI; Periventricular hemorrhagic infarction; TAFI; Thrombin-activatable fibrinolysis inhibitor; t-PA; Tissu
Liver transcriptional profile of atherosclerosis-related genes in human nonalcoholic fatty liver disease
Keywords: بازدارنده فعال کننده پلاسمینوژن; ACE; angiotensin I-converting enzyme; BIRC3; baculoviral IAP repeat-containing 3; CRP; C-reactive protein; CSF2; colony-stimulating factor 2; IL1A; interleukin 1 alpha; IL3; interleukin 3; IL4; interleukin 4; IL6; interleukin; sICAM-1; intercellular adhes
Analysis of Gene Expression Profiles in Fatal Hepatic Failure After Hepatectomy in Mice
Keywords: بازدارنده فعال کننده پلاسمینوژن; plasminogen activator inhibitor; extracellular matrix; mitogen activation protein kinase; cyclin; cDNA microarray; hepatic failure; hepatectomy
Are there new therapeutic options for treating lung cancer based on herbal medicines and their metabolites?
Keywords: بازدارنده فعال کننده پلاسمینوژن; Herbal medicine; Phytochemical; Lung cancer; Molecular targets; Apoptosis; Angiogenesis; BBSKE; 1,2-[bis (1,2-benzisoselenazolone-3 (2H)-ketone)] ethane; bFGF; basic fibroblast growth factor; CAM; complementary and alternative medicine; COX; cyclooxygenas
Enhanced Expression of Plasminogen Activator Inhibitor May Prevent Cardiac Rupture in Female and Castrated Mice After Myocardial Infarction
Keywords: بازدارنده فعال کننده پلاسمینوژن; gender; mice; myocardial infarction; orchiectomy; oophorectomy; plasminogen activator inhibitor
Extracellular proteases in epilepsy
Keywords: بازدارنده فعال کننده پلاسمینوژن; ADAM; a disintegrin and metalloproteinase; ADAMTS; a disintegrin and metalloproteinase with thrombospondin motifs; CCI; controlled cortical impact; ECM; extracellular matrix; ECS; electroconvulsive shock; FH; complement inhibitor; GCD; granule cell disper
Leptin upregulates the expression of plasminogen activator inhibitor-1 in human vascular endothelial cells
Keywords: بازدارنده فعال کننده پلاسمینوژن; PAI-1, plasminogen activator inhibitor-1; tPA, tissue-type plasminogen activator; HCAEC, human coronary artery endothelial cells; MAPK, mitogen activated protein kinasesLeptin; Plasminogen activator inhibitor; Atherosclerosis; Obesity; Fibrinolysis
Optimizing Chemotherapy Regimens for Patients With Early-Stage Breast Cancer
Keywords: بازدارنده فعال کننده پلاسمینوژن; Anthracyclines; HER2; Plasminogen activator inhibitor; Taxanes; Urokinase plasminogen activator
In vitro effects of detergent sclerosants on fibrinolytic enzymes and inhibitors
Keywords: بازدارنده فعال کننده پلاسمینوژن; Detergent sclerosants; Fibrinolysis; Plasminogen; Tissue plasminogen activator; Plasminogen activator inhibitor; Thrombin activatable fibrinolysis inhibitor
Transition of pathophysiological significance of plasminogen activator inhibitor—From a chief player in antiinflammation, antifibrinolysis to that in the development of insulin resistance
Keywords: بازدارنده فعال کننده پلاسمینوژن; Plasminogen activator inhibitor; Inflammation; Fibrinolysis; Lifestyle-related disease
P53 tumor suppressor factor, plasminogen activator inhibitor, and vascular endothelial growth factor gene polymorphisms and recurrent implantation failure
Keywords: بازدارنده فعال کننده پلاسمینوژن; P53 tumor suppressor factor; plasminogen activator inhibitor; vascular endothelial growth factor; gene polymorphisms; recurrent pregnancy loss
Gene polymorphisms related to angiogenesis, inflammation and thrombosis that influence risk for oral cancer
Keywords: بازدارنده فعال کننده پلاسمینوژن; Oral cancer; Polymorphism; Matrix metalloproteinase; Plasminogen activator inhibitor; Angiotensin converting enzyme; Regression analysis
Expression of urokinase-type plasminogen activator system in prostate cancer: Correlation with clinicopathological outcomes in patients undergoing radical prostatectomy
Keywords: بازدارنده فعال کننده پلاسمینوژن; Prostate cancer; Radical prostatectomy; Urokinase-type plasminogen activator; Urokinase-type plasminogen activator receptor; Plasminogen activator inhibitor
Effects of nicotine and lipopolysaccharide on the expression of matrix metalloproteinases, plasminogen activators, and their inhibitors in human osteoblasts
Keywords: بازدارنده فعال کننده پلاسمینوژن; Lipopolysaccharide; Nicotine; Matrix metalloproteinases; Tissue inhibitors of metalloproteinases; Plasminogen activator; Plasminogen activator inhibitor; Osteoblasts
VEGF and angiogenesis in acute and chronic MOG(35–55) peptide induced EAE
Keywords: بازدارنده فعال کننده پلاسمینوژن; EAE; Multiple sclerosis; MS; Angiogenesis; VEGF; Remyelination; Alanyl aminopeptidase; Plasminogen activator inhibitor; Caspase 8; Thrombospondin; Hif1a; MMP-19; Laminin; SU5416
Genetic Risk Factors in Young Patients With Ischemic Colitis
Keywords: بازدارنده فعال کننده پلاسمینوژن; ACE; angiotensin-converting enzyme; APC; activated protein C; Apo; apolipoprotein; FVL; factor V Leiden; GPIIIa; glycoprotein IIIA; HC; healthy controls; IC; ischemic colitis; MTHFR; methylenetetrahydrofolate reductase; PAI; plasminogen activator inhibito
Relationship between maternal and cord blood hemostatic disturbances in preeclamptic pregnancies
Keywords: بازدارنده فعال کننده پلاسمینوژن; tPA; tissue type plasminogen activator; D-dimer; fibrin fragments; PAI; plasminogen activator inhibitor; PE; preeclampsia; SGA; small for gestational age; AGA; adequate for gestational age; LGA; large for gestational age.; Endothelial dysfunction; PAI-1;